Kenneth Pienta, Chief Medical Officer at Cue Biopharma, Inc. (CUE), sold 24,548 shares at $15.15 ($371K) on 2021-02-16, disclosed to the SEC on 2021-02-18.
Open-market sale of $371k CUE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.15 | 16,000 | $242K | 65.3% |
| 2 | $15.06 | 4,274 | $64K | 17.3% |
| 3 | $15.06 | 4,274 | $64K | 17.3% |
| Total | $15.12 avg | 24,548 | $371K | 100% |
| Filing → |
| CUE | BUY | 2021-01-22 | $41K | — | Filing → |
| CUE | BUY | 2018-01-19 | $15K | — | Filing → |
| CRIS | BUY | 2013-11-08 | $44K | — | Filing → |